Clinical Trial Update: The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating trilaciclib for bone marrow protection during chemotherapy in advanced biliary tract cancer and pancreatic cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Pancreatic Cancer

Drugs mentioned

• trilaciclib (trilaciclib)

Snippet

Sponsor: The Second Affiliated Hospital of Shandong First Medical University | Conditions: Biliary Tract Neoplasms, Pancreatic Neoplasms | Phase 2 | Status: NOT_YET_RECRUITING